The University of California San Diego’s Holocaust Living History Workshop (HLHW) is returning this fall with a yearlong series of eight talks that underscore the theme “Rethinking Genocide: Fascism, Exploitation and the Holocaust.” Click here […]
UC San Diego engineers developed microrobots, that can swim around in the lungs, deliver medication and be used to clear up life-threatening cases of bacterial pneumonia. In mice, the microrobots safely eliminated pneumonia-causing bacteria in […]
Seeking solutions to counteract a rapid rise in plastic trash, scientists at UC San Diego have developed biodegradable material that is designed to replace conventionally used plastic. In a new study, an interdisciplinary team of […]
LA JOLLA—With a five-year, $126 million grant from the National Institutes of Health (NIH), a team led by Salk Institute scientists has launched a new Center for Multiomic Human Brain Cell Atlas. Part of the […]
With a $126 million grant from the National Institutes of Health, a multi-institution team of researchers at UC San Diego, Salk Institute and elsewhere has launched a new Center for Multiomic Human Brain Cell Atlas […]
The CDMO outfit iBio has netted a deal that sees it gain access to an AI-based platform as well as new therapeutic candidates as it looks to dive further into drug discovery. iBio closed on […]
Five UC San Diego bioengineering and bioinformatics graduate students have been honored as 2023 Siebel Scholars. The Siebel Scholars program recognizes the most talented students in the world’s leading graduate schools of business, computer science, […]
Right around the beginning of the year, we got a close-up look at what happens after a boom ripples through biotech. The crash of life sciences stocks in Q1 was heard around the world. In […]
The inaugural conference spotlights the potential of genomics and personalized medicine to transform healthcare Click here to view original post
2022 Q4: $52.5 million Net Sales (+18%), $3.1 million Net Income, and $0.52 Diluted EPS CARLSBAD, Calif., Sept. 21, 2022 /PRNewswire/ — Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), a leading formulator, manufacturer, and marketer […]
In 2025, the UC San Diego Health – Hillcrest Medical Campus will be home to a new center named in honor of beloved physician and breast cancer expert, Barbara Parker, MD, thanks to a $10 […]
A national team of scientists, led by researchers at UC San Diego, have created a machine-learning algorithm for diagnosing both MIS-C and Kawasaki disease, two similar pediatric inflammatory conditions with different treatments. Click here to […]
French vaccine company Valneva and German CDMO IDT Biologika have decided to terminate their manufacturing collaboration for Valneva’s Covid-19 vaccine. IDT Biologika was originally tasked with making Valneva’s VLA2001 vaccine, but the deal has been […]
Cidara Therapeutics wants to make its mark in the world of antifungals, and thanks to the FDA, it may get there soon. The San Diego-based company announced Tuesday that the FDA has given priority review […]
Fall Protection remains top citation for 12th year in a row SAN DIEGO, Sept. 20, 2022 /PRNewswire/ — The Occupational Safety and Health Administration announced Tuesday its preliminary Top 10 most frequently cited workplace safety […]
SAN DIEGO, Sept. 20, 2022 /PRNewswire/ — Infixion Bioscience, a pre-clinical drug discovery company focused on developing gene-targeted therapeutics for the rare genetic disorder Neurofibromatosis Type 1 (NF1), announced today the awarding of its third […]
The UC San Diego FIRST Program will recruit 12 diverse, early-career research faculty in the biomedical sciences and the implement strategies to improve faculty recruitment, retention, success and inclusion. Click here to view original post
UC San Diego researchers developed soft devices containing algae that glow in the dark when experiencing mechanical stress, such as being squished, stretched, twisted or bent. The devices do not need electronics to produce light, […]
SAN DIEGO–(BUSINESS WIRE)– #CARNK–Artiva Biotherapeutics Announces FDA Allowance of IND for AB-201, a HER2-Targeted CAR-NK for the Treatment of Solid Tumors Click here to view original post
SAN DIEGO & SINGAPORE–(BUSINESS WIRE)–ImmunoScape has raised $14M in new financing from Anzu Partners, Amgen Ventures, and EDBI to advance its therapeutic candidates toward the clinic Click here to view original post
While several companies have been finding success in the TCR-T cell therapy space — with Intellia having its treatment accepted by the FDA last year — another company is using machine learning to get in […]
A multidisciplinary team led by researchers at UC San Diego has received $1.2 million from the National Science Foundation (NSF) to create a novel system to study and inform the treatment of chronic low back […]
SAN DIEGO, Sept. 19, 2022 /PRNewswire/ — Illumina, Inc. (Nasdaq: ILMN) will host its 2022 Investor Day on Monday, October 3rd starting at 8:00am Pacific Time in San Diego, CA. The event will feature presentations […]
The FDA just gave Heron Therapeutics a win for its post-surgery nausea and vomiting drug — and its fourth approval so far. The San Diego biotech put out word Friday that the FDA approved its […]
UC San Diego Health now offers a novel therapy option shown to extend the lifespan and improve quality of life for certain patients. Click here to view original post
Aviation’s growing impact on the climate crisis requires radical solutions that may upend the industry, according to a new Nature commentary article from the University of California San Diego School of Global Policy and Strategy. […]
Company Combines Existing NR2F6 and Survivin Gene Silencing Findings with Second Generation Checkpoint Inhibitor Approach SAN DIEGO, Sept. 19, 2022 /PRNewswire/ — Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today filing […]
Speakers will discuss how genomics drives more informed, inclusive, and proactive care SAN DIEGO, Sept. 19, 2022 /PRNewswire/ — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that […]
Monitoring the amount of oxygen in your blood could one day be done using your smartphone, shows a study by the University of California San Diego and University of Washington. This could help patients keep […]
SAN DIEGO, Sept. 19, 2022 /PRNewswire/ — Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present data demonstrating sustained improvements with long-term INGREZZA® (valbenazine) capsules treatment in adults with tardive dyskinesia (TD) at […]
Copyright © 2022 Biotech Networks, LLC
